Skip to main content
Caplight Logo









Prevision Medicine AG

Prevision Medicine AG

Private
SchlierenHealthcare & Life Scienceshttps://previsionmedicine.com/

Last Round

Grant

Mar 6, 2026

Total Funding Raised

$220,000

Momentum

Top 1%

of companies Caplight tracks

Company Overview

Prevision Medicine AG is a biotechnology company that provides a functional precision oncology platform to guide personalized cancer treatment decisions.

Sector

Healthcare & Life Sciences

Verticals

Precision Medicine, Biotechnology, Healthcare Analytics

Business Model

B2B

Customer Profile

Services & Consulting, Usage-Based SaaS

AI Layer

Application

Keywords

precision medicineex vivo drug screeningfunctional precision medicinedrug sensitivity testingtechbiopersonalized oncologycancer diagnosticsdeep morphology learningclinical decision supportsingle-cell analysispatient-derived modelsresearch-use-onlyRUOorganoid screeningai-driven drug discovery

Historical Pricing

Historical view of private secondary pricing and transaction trends.

Unlock Pricing Charts

Sign up to view complete historical pricing and secondary transactions.

Caplight Momentum Score

Proprietary index based on bid/ask volume and sentiment.

View Momentum History

Track how buyer interest and sentiment changes over time.

Prevision Medicine AG Comparables

Compare Prevision Medicine AG with similar companies based on industry and business-model similarity.

Prevision Medicine AG comparables — related companies by embedding similarity
CompanySimilarityMarket Cap
KYAN Technologies
84%
First Ascent Biomedical
83%
Travera
82%

Prevision Medicine AG Funding Rounds

Historical fundraising activity

Data table
RoundDateAmount RaisedValuationInvestorsSources
GrantMar 6, 2026
GrantNov 6, 2025
Pre SeedSep 8, 2025
AngelSep 1, 2025

Key People

Founding team and executive leadership

Philip Zimmermann

CEO and Co-Founder

Founding Team

Prevision Medicine AG Investors

Notable investors and investment history

Prevision Medicine AG investors
InvestorRounds
EPFL Innovation ParkGrant

Market signals

Structured signals derived from secondary market and firmographic data.

  • Aug 24, 2026

    Grew 30% QoQ, from 10 to 13 employees.

  • Aug 21, 2026

    Monthly visitors grew 308% MoM, from 51 to 208.

Recent news

Latest coverage and updates

  • receives_financingSep 24, 2026

    Prevision Medicine AG received financing of $5.4M in Seed on Sep 24th '26.

Prevision Medicine AG Filings

Explore SEC and related filing metadata, where available.

Prevision Medicine AG filings preview — column headings only; records require access
TypeDateAmount OfferedAmount SoldFilingPagesDownload

Filing documents are not displayed on this public page. Request access to learn about available coverage.

Request access

Frequently Asked Questions

Common questions about Prevision Medicine AG's valuation, stock price, and market status.

Is Prevision Medicine AG a public or private company?

Prevision Medicine AG is a private company.

What is the current stock price of Prevision Medicine AG?

Prevision Medicine AG is a private company with no public stock price. No recent secondary market data is available.

How much is Prevision Medicine AG worth (valuation)?

Valuation information for Prevision Medicine AG is not publicly available.

Can I buy Prevision Medicine AG stock?

Prevision Medicine AG shares may be available on secondary markets subject to transfer restrictions. Caplight facilitates secondary market transactions for accredited investors. Visit https://www.caplight.com to learn more.

When was Prevision Medicine AG's last funding round?

Prevision Medicine AG's most recent funding round was Grant on March 6, 2026.

Who are the main investors in Prevision Medicine AG?

Key investors in Prevision Medicine AG include EPFL Innovation Park.

Will Prevision Medicine AG IPO soon?

No public IPO plans have been announced for Prevision Medicine AG.

How can I track Prevision Medicine AG secondary market activity?

Caplight tracks bids, offers, and trades for private companies. Visit https://www.caplight.com to monitor Prevision Medicine AG's secondary market activity and sign up for updates.

Firmographic Details

HeadquartersSchlieren
Employee Range7
Year Founded2024
Last FundingMar 6, 2026

Institutional Data Access

Join leading institutional investors using Caplight to access private market data, discover pricing, and execute secondary block trades.

Requires verified institutional or accredited status.

See something wrong or outdated?